Jun 18 |
Shareholders in Travere Therapeutics (NASDAQ:TVTX) are in the red if they invested five years ago
|
May 28 |
Travere gains on Novartis data for Filspari rival, Calliditas buyout
|
May 9 |
Travere Therapeutics to Present at National Kidney Foundation Spring Clinical Meetings and the 61st European Renal Association Congress
|
May 8 |
Loss-Making Travere Therapeutics, Inc. (NASDAQ:TVTX) Expected To Breakeven In The Medium-Term
|
May 7 |
Travere Therapeutics Inc (TVTX) Q1 2024 Earnings Call Transcript Highlights: Navigating Growth ...
|
May 7 |
Travere Therapeutics, Inc. (TVTX) Q1 2024 Earnings Call Transcript
|
May 6 |
Travere Therapeutics Non-GAAP EPS of $1.51 beats by $2.30, revenue of $41.37M misses by $2.25M
|
May 6 |
Travere Therapeutics Reports First Quarter 2024 Financial Results
|
May 5 |
Travere Therapeutics Q1 2024 Earnings Preview
|
Apr 29 |
Travere Therapeutics to Report First Quarter 2024 Financial Results
|